Latest News - Corporate Lawsuits

Tuesday, January 02, 2018 | Corporate Lawsuits, Valeant

Pershing Square, Valeant to Pay $290 Million to End Lawsuit

Activist investor Bill Ackman’s Pershing Square Holdings Ltd. and Valeant Pharmaceuticals International Inc. agreed to pay $290 million to settle investor claims that they engaged in insider tra…

Read the full story

Tuesday, December 26, 2017 | Corporate Lawsuits, Earnings & Financials, Ocular Therapeutix

Ocular Therapeutix Provides Legal Update

Ocular Therapeutix provided an update on legal matters related to the company’s manufacture of its product candidate, Dextenza (dexamethasone insert) 0.4mg. As the company previously disclose…

Read the full story

Monday, December 04, 2017 | Corporate Lawsuits

US Judge Refuses to Dismiss Allergan Suit Against Imprimis

A US judge has refused to dismiss an Allergan lawsuit that claims Imprimis Pharmaceuticals unfairly sells unapproved new drugs under the guise of compounding and engages in false and misleading advert…

Read the full story

Monday, October 16, 2017 | Corporate Lawsuits, Allergan

Allergan Shares Slip As Judge Invalidates Patent on Top Selling Eye Drop

A federal judge struck down patents protecting one of Allergan’s top-selling drugs, sending shares in the company down nearly 5 percent, according to a report in the Financial Times. The Texa…

Read the full story

Monday, October 02, 2017 | Corporate Lawsuits, Dry Eye, Allergan, Shire

Shire Alleges Allergan Blocked Drug From Medicare Contracts

Shire filed an antitrust suit against Allergan alleging Allergan’s contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access to Shire’s rival drug, ac…

Read the full story

Monday, September 18, 2017 | Corporate Lawsuits, Patents, Allergan

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan caused a lot of hand-wringing in the biotech community and excitement among patent lawyers, when the drugmaker announced it would transfer patents for Restasis, Allergan's longstandi…

Read the full story

Monday, September 11, 2017 | Corporate Lawsuits, Imprimis Pharmaceuticals

Imprimis Releases Statement Regarding Allergan Lawsuit

Imprimis Pharmaceuticals responded to a press release issued by Allergan regarding a lawsuit Allergan USA filed against Imprimis. A portion of the Imprimis statement reads: "Imprimis will aggr…

Read the full story

Friday, September 08, 2017 | Corporate Lawsuits, Allergan

Allergan Files Suits Against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida

Allergan USA has filed lawsuits against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida, alleging that those companies are unlawfully manufacturing and selling unapproved new d…

Read the full story

Tuesday, August 22, 2017 | Corporate Lawsuits, Sightpath Medical

Minneapolis Eye Surgery Company Will Pay $12 Million in Alleged Kickbacks Case

A Minneapolis mobile ophthalmic company and its former CEO have agreed to pay $12 million to resolve allegations that it lured physicians with illegal kickbacks in exchange for their business for near…

Read the full story

Thursday, August 10, 2017 | Corporate Lawsuits, Patents, PhysIOL sa

PhysIOL: Company Successful in Patent Infringement Action Protecting FINEVISION IOLs

PhysIOL has claimed that the Dusseldorf District Court in Germany has confirmed that VSY Biotechnology infringes the European Patent EP 2 503 962 of PhysIOL S.A. In its judgment on June 29, 2017, the …

Read the full story

Sunday, July 02, 2017 | Corporate Lawsuits, Allergan

Allergan Settles Whistle-Blower Lawsuit

Allergan settled a whistle-blower lawsuit brought by two Philadelphia-area ophthalmologists who alleged the company provided paid speaking engagements, free business consulting, and other services as …

Read the full story

Wednesday, April 19, 2017 | Corporate Lawsuits, Allergan

Allergan, Argentum Settle Patent Dispute Over Restasis

U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, …

Read the full story

Thursday, March 30, 2017 | Corporate Lawsuits

Carl Zeiss Meditec Wins Patent Infringement Action on Trifocal IOL; VSY to Appeal Decision

Carl Zeiss Meditec has won a patent infringement action before the District Court of Düsseldorf/Germany against VSY Biotechnology BV and its exclusive supplier Fritz Ruck Ophthalmologische System…

Read the full story

Tuesday, March 28, 2017 | Corporate Lawsuits, Valeant

Former Valeant CEO Michael Pearson Sues Company Over Unpaid Share Award

Former Valeant Pharmaceuticals CEO Michael Pearson filed a lawsuit in the US claiming that the company failed to deliver 3 million shares promised to him as part of an exit package. According to the c…

Read the full story

Tuesday, January 17, 2017 | Corporate Lawsuits, Bausch+Lomb

Bausch + Lomb Successfully Defends Patent Covering PreserVision Eye Vitamins in Case vs. Vitamin Health Inc.

Bausch + Lomb announced it has resolved its patent infringement lawsuit vs. Vitamin Health, filed in September 2013 in the U.S. District Court for the Western District of New York. Among other claims,…

Read the full story
Load More